Mar 18, 2016: At the IATA World Cargo Symposium in Berlin, the Amsterdam Airport Schiphol logistics community announced to launch a closed pharma chain programme that will be IATA CEIV Pharma-certified, and will offer pharma manufacturers new levels of transparency.
The initiative is the brain-child of Schiphol’s Pharma Task Force, launched in July 2015 by Air Cargo Netherlands, the Dutch Air Cargo Industry Association, and supported by a number of organisations at the airport.
The new pharma chain has been branded “Pharma Gateway Amsterdam - Qualified & Transparent”.
Its objective is to create a ‘closed’ pharma chain at the airport, further developing Schiphol’s pharma proposition. Schiphol is already one of Europe’s largest gateways for pharma traffic.
Pharma Gateway Amsterdam aims to support a certified track from the shipper, all the way to the consignee; it will achieve this locally by involving airlines, handlers, hauliers and logistics service providers – all of which will be certified to the IATA CEIV Pharma standard.
By the time of its unveiling at IATA WCS, Pharma Gateway Amsterdam had already recruited WFS, DNATA, Swissport, Air France KLM Martinair Cargo, De Jong Special Services, D.J. Middelkoop & Zn., Jan de Rijk Logistics, IJS Global/GEFCO, VCK Logistics, Yusen Logistics and Cyberfreight as members; more companies are expected to join in the near future.
Driving force behind the Pharma Gateway Amsterdam programme is Ferry van der Ent of Air Cargo Netherlands, who says, “We are targeting quality and transparency by closely linking all service providers, and setting uniform standards and procedures. At the same time, we’ll continue to offer shippers and their forwarders a choice of partners in their new, closed supply chain.”
“We have adopted CEIV as our base, as it’s the only truly worldwide standard today. Slowly but surely, more logistics partners are choosing CEIV, driven by shipper demand. And, although it’s not mandatory yet, it may be in the future. We cannot rule out the adoption of even higher standards in due course,” he continues.